Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1,700 VND
254.62 B VND
1.99 T VND
82.86 M
About IMEXPHARM CORPORATION
Sector
CEO
Dao Thi Tran
Headquarters
Cao Lanh
Website
Founded
1977
ISIN
VN000000IMP0
FIGI
BBG000PP6BN0
Imexpharm Corp. engages in the manufacture, import, export and trade of pharmaceuticals, medicinal chemicals and botanical. Its other activities include import and export of medical equipment and instrument; purchasing of materials used for processing its products; wholesale of competent, functional food, drinking water, carbonated water alcohol; and provision of storage services of drugs and medicine raw materials. The company was founded in 1977 and is headquartered in Cao Lanh, Vietnam.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of IMP is 44,000 VND — it has decreased by −1.35% in the past 24 hours. Watch IMEXPHARM CORPORATION stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HOSE exchange IMEXPHARM CORPORATION stocks are traded under the ticker IMP.
IMP stock has fallen by −2.00% compared to the previous week, the month change is a −7.66% fall, over the last year IMEXPHARM CORPORATION has showed a 67.18% increase.
We've gathered analysts' opinions on IMEXPHARM CORPORATION future price: according to them, IMP price has a max estimate of 46,000.00 VND and a min estimate of 41,200.00 VND. Watch IMP chart and read a more detailed IMEXPHARM CORPORATION stock forecast: see what analysts think of IMEXPHARM CORPORATION and suggest that you do with its stocks.
IMP stock is 1.83% volatile and has beta coefficient of 0.19. Track IMEXPHARM CORPORATION stock price on the chart and check out the list of the most volatile stocks — is IMEXPHARM CORPORATION there?
Today IMEXPHARM CORPORATION has the market capitalization of 6.78 T, it has increased by 0.44% over the last week.
Yes, you can track IMEXPHARM CORPORATION financials in yearly and quarterly reports right on TradingView.
IMEXPHARM CORPORATION is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
IMP net income for the last quarter is 67.14 B VND, while the quarter before that showed 65.92 B VND of net income which accounts for 1.86% change. Track more IMEXPHARM CORPORATION financial stats to get the full picture.
Yes, IMP dividends are paid annually. The last dividend per share was 1.00 K VND. As of today, Dividend Yield (TTM)% is 1.03%. Tracking IMEXPHARM CORPORATION dividends might help you take more informed decisions.
IMEXPHARM CORPORATION dividend yield was 1.77% in 2023, and payout ratio reached 27.49%. The year before the numbers were 1.66% and 33.89% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 10, 2024, the company has 1.42 K employees. See our rating of the largest employees — is IMEXPHARM CORPORATION on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IMEXPHARM CORPORATION EBITDA is 462.44 B VND, and current EBITDA margin is 23.25%. See more stats in IMEXPHARM CORPORATION financial statements.
Like other stocks, IMP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IMEXPHARM CORPORATION stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IMEXPHARM CORPORATION technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IMEXPHARM CORPORATION stock shows the buy signal. See more of IMEXPHARM CORPORATION technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.